Holen Sie sich die Stockscreener-App
73.65
0.87%
-0.65
Handel nachbörslich:
73.65
Schlusskurs vom Vortag:
$74.30
Offen:
$74.77
24-Stunden-Volumen:
2.57M
Relative Volume:
1.04
Marktkapitalisierung:
$11.74B
Einnahmen:
$705.14M
Nettoeinkommen (Verlust:
$-453.90M
KGV:
-24.23
EPS:
-3.04
Netto-Cashflow:
$-551.29M
1W Leistung:
+0.90%
1M Leistung:
+6.51%
6M Leistung:
+124.68%
1J Leistung:
+90.02%
1-Tages-Spanne:
$71.95
$75.25
1-Wochen-Bereich:
$71.14
$75.49
52-Wochen-Spanne:
$23.95
$75.49
Ionis Pharmaceuticals Inc Stock (IONS) Company Profile
Firmenname
Ionis Pharmaceuticals Inc
Sektor
Branche
Telefon
(760) 931-9200
Adresse
2855 GAZELLE COURT, CARLSBAD, CA
Vergleichen Sie IONS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IONS
Ionis Pharmaceuticals Inc
|
73.65 | 12.03B | 705.14M | -453.90M | -551.29M | -3.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Ionis Pharmaceuticals Inc Stock (IONS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-08 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-09-26 | Hochstufung | Goldman | Sell → Neutral |
| 2025-09-03 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2025-07-31 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-07-01 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-04-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-03-31 | Eingeleitet | Redburn Atlantic | Neutral |
| 2024-08-02 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2024-07-24 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-07-16 | Fortgesetzt | Jefferies | Buy |
| 2024-06-14 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2024-04-10 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2024-01-02 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-10-23 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-09-29 | Eingeleitet | Raymond James | Strong Buy |
| 2023-07-31 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-06-07 | Fortgesetzt | Piper Sandler | Overweight |
| 2023-05-04 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-03-21 | Eingeleitet | Bernstein | Underperform |
| 2022-12-21 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-09-09 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-07-18 | Fortgesetzt | Oppenheimer | Outperform |
| 2022-03-31 | Fortgesetzt | Piper Sandler | Overweight |
| 2022-03-01 | Eingeleitet | Citigroup | Sell |
| 2022-03-01 | Eingeleitet | Guggenheim | Buy |
| 2022-02-01 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-12-14 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2021-05-07 | Hochstufung | UBS | Sell → Neutral |
| 2021-03-01 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2020-12-16 | Eingeleitet | UBS | Sell |
| 2020-12-15 | Hochstufung | Cowen | Market Perform → Outperform |
| 2020-09-14 | Fortgesetzt | JP Morgan | Neutral |
| 2020-09-02 | Eingeleitet | The Benchmark Company | Hold |
| 2020-06-01 | Fortgesetzt | Oppenheimer | Outperform |
| 2020-05-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2019-12-13 | Eingeleitet | Oppenheimer | Outperform |
| 2019-11-13 | Eingeleitet | BofA/Merrill | Buy |
| 2019-11-07 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2019-09-10 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2018-08-08 | Bestätigt | Stifel | Hold |
| 2018-08-07 | Bestätigt | Stifel | Hold |
| 2018-05-08 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2017-10-06 | Fortgesetzt | Goldman | Sell |
| 2017-08-17 | Eingeleitet | Evercore ISI | Outperform |
| 2017-08-09 | Bestätigt | Stifel | Hold |
| 2017-03-10 | Herabstufung | Goldman | Neutral → Sell |
| 2016-12-28 | Bestätigt | BMO Capital Markets | Outperform |
| 2016-12-27 | Bestätigt | Leerink Partners | Mkt Perform |
Alle ansehen
Ionis Pharmaceuticals Inc Aktie (IONS) Neueste Nachrichten
Insider Sell: Richard Geary Sells 90,929 Shares of Ionis Pharmac - GuruFocus
Ionis Pharma director Loscalzo sells $1.2m in shares By Investing.com - Investing.com Philippines
Ionis Pharmaceuticals EVP Geary sells $6.8m in IONS stock By Investing.com - Investing.com Philippines
Ionis Pharmaceuticals director Wender sells $2m in IONS stock By Investing.com - Investing.com Australia
Ionis Pharmaceuticals EVP Geary sells $6.8m in IONS stock - Investing.com
Ionis Pharmaceuticals director Wender sells $2m in IONS stock - Investing.com
Published on: 2025-11-03 08:52:47 - newser.com
Is Ionis Pharmaceuticals Inc. (ISI) stock attractive post correctionMarket Growth Summary & Weekly Setup with High ROI Potential - newser.com
How Ionis Pharmaceuticals Inc. stock trades during market volatility2025 Price Momentum & Smart Money Movement Tracker - newser.com
Is Ionis Pharmaceuticals Inc. (ISI) stock undervalued after correctionProfit Target & Fast Moving Trade Plans - newser.com
Price momentum metrics for Ionis Pharmaceuticals Inc. explainedBreakout Watch & Step-by-Step Swing Trade Plans - newser.com
Why Ionis Pharmaceuticals Inc. stock attracts high net worth investorsMarket Risk Summary & Weekly High Potential Stock Alerts - newser.com
How Ionis Pharmaceuticals Inc. (ISI) stock compares with tech leadersJuly 2025 Setups & Safe Capital Growth Stock Tips - newser.com
Volatility clustering patterns for Ionis Pharmaceuticals Inc.July 2025 Outlook & Precise Trade Entry Recommendations - newser.com
Why Ionis Pharmaceuticals Inc. stock remains on watchlists2025 Analyst Calls & AI Driven Stock Reports - newser.com
Is Ionis Pharmaceuticals Inc. stock ready for breakoutJuly 2025 Market Mood & Risk Controlled Daily Trade Plans - newser.com
37,649 Shares in Ionis Pharmaceuticals, Inc. $IONS Bought by Y Intercept Hong Kong Ltd - MarketBeat
Will Ionis Pharmaceuticals Inc. (ISI) stock profit from AI boomPortfolio Risk Summary & Growth Focused Entry Point Reports - newser.com
Why ETFs are accumulating Ionis Pharmaceuticals Inc. (ISI) stockWeekly Profit Report & Proven Capital Preservation Methods - newser.com
Is Ionis Pharmaceuticals Inc. (ISI) stock a fit for income portfoliosMarket Sentiment Review & Free Safe Entry Trade Signal Reports - newser.com
Is Ionis Pharmaceuticals Inc. stock poised for growth2025 Market Overview & Weekly Market Pulse Updates - newser.com
Wall Street Zen Downgrades Ionis Pharmaceuticals (NASDAQ:IONS) to Hold - MarketBeat
Can Ionis Pharmaceuticals Inc. stock hit analyst price targetsWeekly Gains Summary & Technical Analysis for Trade Confirmation - newser.com
Earnings Update: Here's Why Analysts Just Lifted Their Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Price Target To US$81.91 - simplywall.st
US$81.91That's What Analysts Think Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Is Worth After These Results - Yahoo Finance
Pinnacle Associates Ltd. Sells 113,978 Shares of Ionis Pharmaceuticals, Inc. $IONS - MarketBeat
Can Ionis Pharmaceuticals Inc. stock resist market sell offsWeekly Trade Review & Capital Efficiency Focused Strategies - newser.com
Candlestick signals on Ionis Pharmaceuticals Inc. stock today2025 Top Gainers & Risk Controlled Daily Trade Plans - newser.com
Published on: 2025-10-31 22:00:20 - newser.com
Ionis Pharmaceuticals (NASDAQ:IONS) Price Target Raised to $99.00 - MarketBeat
Ionis Pharmaceuticals (NASDAQ:IONS) Sets New 1-Year High on Earnings Beat - MarketBeat
Royal Bank Of Canada Issues Positive Forecast for Ionis Pharmaceuticals (NASDAQ:IONS) Stock Price - MarketBeat
Ionis Pharmaceuticals (NASDAQ:IONS) Given Strong-Buy Rating at Raymond James Financial - MarketBeat
Ionis Pharmaceuticals (NASDAQ:IONS) Price Target Raised to $90.00 at Needham & Company LLC - MarketBeat
Will Ionis Pharmaceuticals Inc. stock deliver better than expected guidance2025 Growth vs Value & AI Enhanced Trading Signals - newser.com
IQ EQ FUND MANAGEMENT IRELAND Ltd Increases Holdings in Ionis Pharmaceuticals, Inc. $IONS - MarketBeat
What is the fair value estimate for Ionis Pharmaceuticals Inc. (ISI) stock in 2025Quarterly Earnings Report & Low Risk High Reward Trade Ideas - newser.com
Finanzdaten der Ionis Pharmaceuticals Inc-Aktie (IONS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):